ADVERTISEMENT

Custom Search
ADVERTISEMENT
Helpdesk Support
Today's Health Headlines
CLEVELAND (Reuters) - Women in Ohio would be prohibited from receiving abortions because of a fetal Down syndrome diagnosis under a bill that passed the state senate on Wednesday and is heading to Republican Governor John Kasich’s desk.

LONDON (Reuters) - It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on research investment at leading pharmaceutical companies are down.

NEW YORK (Reuters) - The number of consumers who signed up for 2018 Obamacare health insurance surpassed the 1 million mark in the second-to-last week of enrollment, the government said on Wednesday, but it did not appear to be enough to grow the program.

(Reuters) - The U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson & Johnson's blockbuster rheumatoid arthritis drug, Remicade, the company said on Wednesday.

(Reuters) - A U.S. appeals court on Wednesday vacated the conviction of the owner of a wholesale drug distributor accused of selling authentic Botox and other drugs with foreign labels, dealing another setback to the government, which has struggled at times to successfully prosecute similar such cases.

CHICAGO (Reuters) - As many as 646,000 people are dying globally from seasonal influenza each year, U.S. health officials said on Wednesday, a rise from earlier assessments of the disease's death toll.

CHICAGO (Reuters) - A new study sheds light on how the mosquito-borne Zika virus causes a rare neurological condition, and the findings could have implications for companies working on Zika vaccines, U.S. researchers said on Wednesday.

ZURICH (Reuters) - Swiss drugmaker Novartis's Sandoz generics business is in the process of selling or closing some products in the United States, it said on Wednesday.

(Reuters) - Revance Therapeutics Inc will wait to seek partnerships with bigger drugmakers until it is closer to regulatory approval for its Botox rival treatment, Chief Executive Dan Browne told Reuters in an interview.

DUBLIN (Reuters) - An Irish parliamentary committee on Wednesday recommended that an abortion referendum due next year should offer the choice of allowing terminations with no restrictions up to 12 weeks into a pregnancy, a more liberal position than some had anticipated.

ADVERTISEMENT
Welcome Guest
Username: 
Password:
Not a member? Sign Up!
Browse RSS Feeds
click here when finished
Save Page Layout
Video
ADVERTISEMENT
loading